Keenan A Walker1, Gregory G Brown2. 1. a Department of Neurology , Johns Hopkins University School of Medicine , Baltimore , MD , USA. 2. b Department of Psychiatry , University of California San Diego , San Diego , CA , USA.
Abstract
OBJECTIVE: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. METHOD: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen's d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. RESULTS: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = -0.34, 95% CI [-0.47, -0.20]) and inhibition (d = -0.31, 95% CI [-0.40, -0.21]), somewhat larger for measures of decision-making (d = -0.41, 95% CI [-0.53, -0.28]) and working memory (d = -0.42, 95% CI [-0.59, -0.29]), and largest for apathy (d = -0.87, 95% CI [-1.09, -0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. CONCLUSIONS: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.
OBJECTIVE: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. METHOD: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen's d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. RESULTS: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = -0.34, 95% CI [-0.47, -0.20]) and inhibition (d = -0.31, 95% CI [-0.40, -0.21]), somewhat larger for measures of decision-making (d = -0.41, 95% CI [-0.53, -0.28]) and working memory (d = -0.42, 95% CI [-0.59, -0.29]), and largest for apathy (d = -0.87, 95% CI [-1.09, -0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. CONCLUSIONS: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.
Authors: Stéfan du Plessis; Matthijs Vink; John A Joska; Eleni Koutsilieri; Asif Bagadia; Dan J Stein; Robin Emsley Journal: J Int Neuropsychol Soc Date: 2015-10-05 Impact factor: 2.892
Authors: Mona A Mohamed; Peter B Barker; Richard L Skolasky; Ola A Selnes; Richard T Moxley; Martin G Pomper; Ned C Sacktor Journal: Magn Reson Imaging Date: 2010-08-04 Impact factor: 2.546
Authors: Eileen M Martin; David L Pitrak; William Weddington; Niles A Rains; Gerald Nunnally; Heather Nixon; Silvana Grbesic; Jasmin Vassileva; Antoine Bechara Journal: J Int Neuropsychol Soc Date: 2004-11 Impact factor: 2.892
Authors: Jennifer E Iudicello; Steven Paul Woods; Jordan E Cattie; Katie Doyle; Igor Grant Journal: Clin Neuropsychol Date: 2012-11-26 Impact factor: 3.535
Authors: Victoria M Kordovski; Kelli L Sullivan; Savanna M Tierney; Steven Paul Woods Journal: J Clin Exp Neuropsychol Date: 2019-11-07 Impact factor: 2.475
Authors: Eileen Martin; M K Keutmann; J S Fogel; P M Maki; R Gonzalez; J Vassileva; L H Rubin; D Hardy Journal: J Neurovirol Date: 2018-04-23 Impact factor: 2.643
Authors: Nina Pocuca; Jared W Young; David A MacQueen; Scott Letendre; Robert K Heaton; Mark A Geyer; William Perry; Igor Grant; Arpi Minassian Journal: Drug Alcohol Depend Date: 2020-08-22 Impact factor: 4.492
Authors: Kirsten Rowe; Mihaela Duta; Nele Demeyere; Ryan G Wagner; Audrey Pettifor; Kathleen Kahn; Stephen Tollman; Gaia Scerif; Alan Stein Journal: AIDS Care Date: 2020-12-01
Authors: T Jordan Walter; Jared W Young; Morgane Milienne-Petiot; D S Deben; Robert K Heaton; Scott Letendre; David J Grelotti; William Perry; Igor Grant; Arpi Minassian Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2020-09-04 Impact factor: 5.067